Table 5.

Patients with clearance of PCD clone.

Patient Number	T-Cell Malignancy	T-cell treatment or PCD treatment first?*	First Line T-Cell Treatment	T-Cell Progression?	PCD	First Line PCD Treatment	PCD Progression After First Line Treatment?	PCD Clearance after T-Cell Treatment?
3	T-LGLL	Only T-cell	MTX	Yes	Plasmacytosis	None	No	Undetermined*
4	PTCL	PCD	CHOEP	No	Plasmacytoma	IFRT	Yes	No
5	T-LGLL	T-cell	Cyclosporine	No	MM	Bortezomib/Lenalidomide/Dexamethasone	Yes	Yes
11	T-LGLL	T-cell	Methotrexate	No	MM	Cyclophosphamide/Dexamethasone	Yes	Yes
13	T-LGLL	PCD	Cyclophosphamide	No	MM	Bortezomib/Lenalidomide/Dexamethasone	No	No
15	T-LGLL	Only T-cell	Cyclophosphamide	Yes	MGUS	None	No	Yes
18	CTCL	Only PCD	None	No	MM	Daratumumab/Lenalidomide	Yes	No
24	CTCL	Only T-cell	Bexarotene/Extracorporeal Photopheresis	No	MGUS	None	No	Yes

Frontline treatment information for patients that had clearance of their PCD cline and whether they received initial treatment for their T-Cell disease or PCD and whether they had progression to front line treatments.

*Exact start date for T-cell malignancy is unknown, but the patient was on Cyclosporine (Known T-LGLL treatment) at the time of PCD clone clearance.